Search Within

Richard D Carvajal

Formats
  1. Journal Article (86)
  2. Meeting Abstract (61)
  3. Book Section (1)
Groups
  1. Department of Medicine (100)
  2. Solid Tumor Oncology Division (98)
  3. Melanoma and Immunotherapeutics Service (57)
  4. GSK Faculty (50)
  5. Biostatistics Service (45)
  6. Epidemiology and Biostatistics (45)

More Groups

People
  1. Gary Schwartz (61)
  2. Jedd Wolchok (41)
  3. Paul Chapman (33)
  4. Mark Dickson (29)
  5. Katherine Panageas (22)
  6. Sandra D'Angelo (20)

More People

Years
  1. 2023 (1)
  2. 2020 (1)
  3. 2019 (2)
  4. 2018 (4)
  5. 2017 (1)
  6. 2016 (4)

More Years

Publications
  1. Journal of Clinical Oncology (57)
  2. Clinical Cancer Research (13)
  3. Annals of Oncology (4)
  4. Cancer (4)
  5. Pigment Cell & Melanoma Research (4)
  6. Annals of Surgical Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (58)
  2. American Association for Cancer Research (18)
  3. Elsevier Inc. (10)
  4. Wiley Blackwell (10)
  5. Springer (9)
  6. Lippincott Williams & Wilkins (7)

More Publishers

Results (148)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of MEK inhibitor selumetinib (AZD6244, ARRY-142886) in patients with BRAFV600E/K-mutated melanoma
    Journal Article

    Catalanotti, F.; Solit, D. B.; Pulitzer, M. P.; Berger, M. F.; Scott, S. N.; Iyriboz, T.; Lacouture, M. E.; Panageas, K. S.; Wolchok, J. D.; Carvajal, R. D.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • Anal versus rectal melanoma: does site of origin predict outcome?
    Journal Article

    Bello, D. M.; Smyth, E.; Perez, D.; Khan, S.; Temple, L. K.; Ariyan, C. E.; Weiser, M. R.; Carvajal, R. D.
    Diseases of the Colon and Rectum (2013)

    Fulltext@MSK | Save
  • Evaluation of the absolute lymphocyte count as a biomarker for melanoma patients treated with the commercially available dose of ipilimumab (3mg/kg)
    Meeting Abstract

    Postow, M. A.; Yuan, J.; Panageas, K.; Bogatch, K.; Callahan, M.; Cheng, M.; Schroeder, S. E. A.; Kendle, R. F.; Harding, J. J.; Dickson, M. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Clinical activity and safety of anti-PD-1 (BMS-936558, MDX-1106) in patients with advanced melanoma (MEL)
    Meeting Abstract

    Hodi, F. S.; Sznol, M.; McDermott, D. F.; Carvajal, R. D.; Lawrence, D. P.; Topalian, S. L.; Wigginton, J.; McDonald, D.; Kollia, G.; Gupta, A. K.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Hypersensitivity skin reactions in melanoma patients treated with vemurafenib after ipilimumab therapy
    Meeting Abstract

    Harding, J. J.; Lacouture, M. E.; Pulitzer, M.; Callahan, M.; Postow, M. A.; Carvajal, R. D.; Wolchok, J. D.; Chapman, P. B.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A first-in-human, phase Ib combination study to assess safety, pharmacokinetics (PK), and pharmacodynamics (PD) of a hedgehog inhibitor, GDC-0449, with a Notch inhibitor, RO4929097, in patients with advanced sarcoma
    Meeting Abstract

    Gounder, M. M.; Dickson, M. A.; Wu, N.; Ivy, S. P.; Carvajal, R. D.; D'Angelo, S. P.; Keohan, M. L.; Qin, L. X.; Erinjeri, J. P.; Takebe, N.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A first-in-human phase I study of MORAb-004 (M4), a humanized monoclonal antibody recognizing endosialin (TEM-1), in patients with solid tumors
    Meeting Abstract

    Diaz, L. A.; Azad, N. S.; Gounder, M. M.; Coughlin, C. M.; Fishel, J.; O'Shannessy, D.; Grasso, L.; Wustner, J.; Aluri, J.; Parno, J.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Activity of sorafenib in radiation-associated breast angiosarcomas harboring MYC and FLT4 amplifications
    Meeting Abstract

    D'Angelo, S. P.; Antonescu, C. R.; Keohan, M. L.; Carvajal, R. D.; Dickson, M. A.; Gounder, M. M.; Moraco, N. H.; Singer, S.; Schwartz, G. K.; Tap, W. D.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Pharmacodynamic activity of selumetinib to predict radiographic response in advanced uveal melanoma
    Meeting Abstract

    Carvajal, R. D.; Ambrosini, G.; Wolchok, J. D.; Chapman, P. B.; Dickson, M. A.; D'Angelo, S. P.; Bluth, M. J.; Paucar, D.; Fusco, A.; Bohr, D.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Randomized multicenter double-blind phase II trial: The immunological adjuvant OPT-821 with or without a trivalent ganglioside vaccine in metastatic sarcoma patients following metastasectomy
    Meeting Abstract

    Carvajal, R. D.; Chugh, R.; Milhem, M. M.; Ryan, C. W.; George, S.; Chmielowski, B.; Agulnik, M.; Rodler, E. T.; Elias, A. D.; Budd, G. T.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save